Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

JILA’s Comb Breathalyzer is Now a Thousandfold More Sensitive to Disease Biomarkers

by Global Biodefense Staff
October 27, 2021
JILA’s Comb Breathalyzer is Now a Thousandfold More Sensitive to Disease Biomarkers

Graduate student Qizhong Liang adjusts JILA's frequency comb breathalyzer, which identifies molecules associated with disease based on colors and amounts of light absorbed inside the tube (left) containing breath samples. Credit: R. Jacobson/NIST

Scientists have dramatically boosted the sensitivity of a laser frequency comb breathalyzer to detect multiple biomarkers of disease. When validated and engineered into a portable design, the comb system could offer real-time, noninvasive analysis of human breath to detect and monitor diseases.

The work was conducted at JILA, a research facility jointly operated by the National Institute of Standards and Technology (NIST) and the University of Colorado Boulder.

The system “fingerprints” chemicals by measuring the colors and amounts of light absorbed as a laser frequency comb passes back and forth through breath samples loaded into a mirrored glass tube. The scientists upgraded an decade-old design to include a shift in the light spectrum analyzed from the near-infrared to the mid-infrared band, where more molecules absorb light, and advances in optical coatings and several other technologies to achieve detection sensitivity up to the parts-per-trillion level.

NIST/JILA Fellows Jun Ye and David Nesbitt detected and monitored four biomarkers — methanol (CH3OH), methane (CH4), water (H2O) and a form of heavy water (HDO) — in the breath of a volunteer. These are indicators of health conditions such as, in the case of methane, intestinal problems. 

The researchers say it is feasible to use the same apparatus to detect six more chemicals: formaldehyde, ethane, carbonyl sulfide, ethylene, carbon disulfide and ammonia. In addition, extending the comb lasers further into the infrared should greatly expand the detection capability and enable the identification of many hundreds of trace breath chemicals. 

JILA researchers demonstrated a prototype comb breathalyzer in 2008 but did not develop it further at that time. They have now refocused on it, prompted by the possibility of eventually testing for COVID-19. 

“We are really quite optimistic and committed to pushing this technology to real medical applications,” Ye said.

The most widely used analytical technique in breath research is gas chromatography combined with mass spectrometry, which can detect hundreds of exhaled molecules but works slowly, requiring tens of minutes. Most optical breath tests approved by the U.S. Food and Drug Administration detect only one chemical. JILA is the only institution that has published research on comb breathalyzers, Ye said.

Breath analysis is the leading medical application for frequency combs. Combs offer a combination of broad spectral coverage, high resolution and high sensitivity, potentially detecting tens of chemicals simultaneously. Among other advantages, the comb system would not require chemical reagents and complex laboratory facilities. 

Ye and Nesbitt are now working with other NIST researchers to engineer a compact version of the breathalyzer.

The work is funded by the Air Force Office of Scientific Research, the National Science Foundation and NIST.

Ultrasensitive multispecies spectroscopic breath analysis for real-time health monitoring and diagnostics. Proceedings of the National Academy of Sciences. 1 October 2021.

Article adapted from NIST

Tags: BiomarkersEditor PickInnovationMultiplex

Related Posts

New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC